Injector and method of assembly
An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product. The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.
1. An injector comprising:
a container including a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir;
a volume of a drug product disposed in the sterile reservoir, the drug product comprising a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)-specific antibody;
a stopper disposed in the container and moveable to expel the drug product from the container during use of the injector;
a fluid delivery system comprising a container needle having a point, the point disposed partially through the seal assembly in a storage state, and disposed through the seal assembly and into the sterile reservoir in a delivery state;
a clean barrier coupled with the needle such that the point penetrates the clean barrier in the storage state;
a septum coupled with the clean barrier such that the septum and the clean barrier define an enclosed clean space disposed between the septum and the clean barrier, the point of the container needle being disposed in the enclosed clean space in the storage state; and
an actuator that is adapted to move the container needle from the storage state to the delivery state.
2. The injector of claim 1 , wherein the wall of the container comprises a rigid wall.
3. The injector of claim 1 , wherein the wall of the container comprises a flexible wall.
4. The injector of claim 1 , wherein the septum consists of a flexible unitary wall having an interior surface that defines the interior surface of the seal assembly.
5. The injector of claim 4 , wherein the wall of the container defines a bore with an opening in fluid communication with a first end of the bore, the stopper being disposed within a second end of the bore and is moveable along the bore.
6. The injector of claim 1 , wherein the septum is disposed across an opening of the container and fixedly attached to the wall of the container.
7. The injector of claim 1 , wherein the seal assembly comprises the septum and the septum includes a first surface in contact with the drug product and a second surface bordering the enclosed clean space.
8. The injector of claim 7 , wherein the wall of the container defines a bore.
9. The injector of claim 1 , wherein the wall of the container defines a bore with an opening in fluid communication with a first end of the bore, and the clean barrier defines a second septum disposed across the opening, the stopper being disposed within a second end of the bore and moveable along the bore.
10. The injector of claim 1 , wherein the fluid delivery system comprises clean flexible tubing connected at a first end to the container needle and a second end operably connected to an injection needle having a second clean barrier that closes off the injection needle.
11. The injector of claim 1 , wherein the actuator is adapted to move the container needle between the storage state and the delivery state.
12. The injector of claim 1 , wherein the actuator is adapted to delay movement of the container needle from the storage state to the delivery state after an input is received.
13. The injector of claim 1 , further comprising a mechanical, electro-mechanical, or electrical input device coupled to the actuator.
14. The injector of claim 1 , wherein the septum consists of a flexible unitary wall.
15. The injector of claim 1 , wherein the clean barrier does not contact the septum.
16. An injector comprising:
a container including a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir;
a volume of a drug product disposed in the sterile reservoir, the drug product comprising a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)-specific antibody;
a stopper disposed in the container and moveable to expel the drug product from the container during use of the injector;
a fluid delivery system comprising a container needle having a point, the point partially disposed through the seal assembly in a storage state, and disposed through the seal assembly and into the sterile reservoir in a delivery state;
an enclosed clean space, the point of the container needle being disposed in the enclosed clean space in the storage state;
the seal assembly including a septum fixed relative to the wall of the container and a clean barrier, the clean barrier being spaced apart from the septum to define the enclosed clean space between the septum and the clean barrier, the septum having a first surface configured to be in contact with the drug product and a second surface bordering the enclosed clean space;
the wall of the container defining a bore with an opening in fluid communication with a first end of the bore, and the clean barrier defining a second septum disposed across the opening and fixed relative to the wall of the container, the stopper being disposed within a second end of the bore and moveable along the bore; and
an actuator that is adapted to move the container needle from the storage state to the delivery state.